Literature DB >> 20874003

Clinical significance of GPR56, transglutaminase 2, and NF-κB in esophageal squamous cell carcinoma.

Tasneem Kausar1, Rinu Sharma, Md Raghibul Hasan, Satyendra Chandra Tripathi, Anoop Saraya, Tushar K Chattopadhyay, Siddartha Datta Gupta, Ranju Ralhan.   

Abstract

Proteins do not operate as individual units, and components of intracellular canonical pathways often cross talk in tumor genesis. We hypothesized that G-protein-coupled receptor 56 (GPR56), transglutaminase (TG2), and nuclear factor-κB (NF-κB) may collaborate in interconnected pathways and contribute to the aggressive behavior of esophageal squamous cell carcinoma (ESCC). Immunohistochemical analysis of GPR56, TG2, and NF-κB was carried out using ESCC tissue microarrays. Immunostaining of all the three proteins revealed a significant increase in their expression in ESCCs as compared with normal epithelia and correlated with their concomitant expression. A significant correlation between GPR56, TG2, and NF-κB was observed that correlated with nodal metastasis and tumor invasion in ESCCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20874003     DOI: 10.3109/07357907.2010.512597

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  16 in total

1.  An unprecedented dual antagonist and agonist of human Transglutaminase 2.

Authors:  Michael C Yi; Brad A Palanski; Steven A Quintero; Nicholas M Plugis; Chaitan Khosla
Journal:  Bioorg Med Chem Lett       Date:  2015-05-15       Impact factor: 2.823

Review 2.  Adhesion GPCRs in Tumorigenesis.

Authors:  Gabriela Aust; Dan Zhu; Erwin G Van Meir; Lei Xu
Journal:  Handb Exp Pharmacol       Date:  2016

3.  MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response.

Authors:  Krishna Sumanth Ghanta; Suresh B Pakala; Sirigiri Divijendra Natha Reddy; Da-Qiang Li; Sujit S Nair; Rakesh Kumar
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

Review 4.  International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.

Authors:  Jörg Hamann; Gabriela Aust; Demet Araç; Felix B Engel; Caroline Formstone; Robert Fredriksson; Randy A Hall; Breanne L Harty; Christiane Kirchhoff; Barbara Knapp; Arunkumar Krishnan; Ines Liebscher; Hsi-Hsien Lin; David C Martinelli; Kelly R Monk; Miriam C Peeters; Xianhua Piao; Simone Prömel; Torsten Schöneberg; Thue W Schwartz; Kathleen Singer; Martin Stacey; Yuri A Ushkaryov; Mario Vallon; Uwe Wolfrum; Mathew W Wright; Lei Xu; Tobias Langenhan; Helgi B Schiöth
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 5.  Pathophysiological impact of the adhesion G protein-coupled receptor family.

Authors:  Jeanette M Einspahr; Douglas G Tilley
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-18       Impact factor: 5.282

6.  Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells.

Authors:  Xiuting Chen; Zhe Ying; Xi Lin; Huanxin Lin; Jueheng Wu; Mengfeng Li; Libing Song
Journal:  J Clin Invest       Date:  2013-05-08       Impact factor: 14.808

7.  TGM2: a cell surface marker in esophageal adenocarcinomas.

Authors:  Deborah T Leicht; Tasneem Kausar; Zhuwen Wang; Daysha Ferrer-Torres; Thomas D Wang; Dafydd G Thomas; Jules Lin; Andrew C Chang; Lin Lin; David G Beer
Journal:  J Thorac Oncol       Date:  2014-06       Impact factor: 15.609

8.  Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis.

Authors:  Raghibul Hasan; Rinu Sharma; Anoop Saraya; Tushar K Chattopadhyay; Siddartha DattaGupta; Paul G Walfish; Shyam S Chauhan; Ranju Ralhan
Journal:  BMC Cancer       Date:  2014-01-02       Impact factor: 4.430

9.  Transglutaminase 2 in human diseases.

Authors:  Zsuzsa Szondy; Ilma Korponay-Szabó; Robert Király; Zsolt Sarang; Gregory J Tsay
Journal:  Biomedicine (Taipei)       Date:  2017-08-25

10.  Slug is a predictor of poor prognosis in esophageal squamous cell carcinoma patients.

Authors:  Md Raghibul Hasan; Rinu Sharma; Anoop Saraya; Tushar K Chattopadhyay; Siddartha DattaGupta; Paul G Walfish; Shyam S Chauhan; Ranju Ralhan
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.